Stocks
Neurocrine Biosciences, Inc.NBIX
NASDAQHealthcareBiotechnology$156.22+1.57%
Price as of · delayed, not real-time
Focused on neuroscience, this biopharmaceutical company develops treatments for neurological, endocrine, and psychiatric disorders. Its commercial products include Ingrezza for tardive dyskinesia and Ongentys for Parkinson’s, with a pipeline targeting high-need CNS conditions. Investors monitor its specialty drug commercialization and late-stage clinical trials in niche neurological markets.
Market Cap: $13.0B52W Range: $122.14-$186.12
Congressional Interest in Neurocrine Biosciences, Inc. (NBIX)
5 members of Congress have disclosed 23 trades in Neurocrine Biosciences, Inc. (NBIX), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 15 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
23
Unique Politicians
5
Buys
8
Sells
15
Who in Congress Is Trading NBIX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-06-17 | Lisa McClain | sell | $1K-$15K |
| 2025-06-11 | Lisa McClain | buy | $1K-$15K |
| 2024-11-19 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2024-09-09 | Rohit Khanna | sell | $1K-$15K |
| 2024-08-26 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2024-08-26 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2023-08-14 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2022-12-14 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2022-01-28 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2022-01-21 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2021-12-15 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2021-12-14 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2020-12-21 | Gilbert Cisneros | buy | $1K-$15K |
| 2020-11-23 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2020-11-23 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2020-11-23 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2020-11-13 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2020-11-12 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2020-10-01 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2020-07-21 | Gilbert Cisneros | sell | $1K-$15K |
| 2019-01-16 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2019-01-11 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2018-12-13 | Josh Gottheimer | sell | $1K-$15K |